Diabetes and hypercholesterolemia among patients with calcific aortic stenosis

Insights

Diabetes and hypercholesterolemia are linked to calcific aortic stenosis. Their combined effect on the prevalence of aortic stenosis appears multiplicative, suggesting a role in disease causation.

Area of Science:

  • Cardiology
  • Metabolic Diseases
  • Epidemiology

Background:

  • Calcific aortic stenosis (CAS) is a common valvular heart disease with incompletely understood etiology.
  • Diabetes mellitus and hypercholesterolemia are recognized cardiovascular risk factors.
  • The specific contribution of these metabolic factors to CAS pathogenesis requires elucidation.

Purpose of the Study:

  • To investigate the association between diabetes and hypercholesterolemia and the prevalence of isolated aortic stenosis.
  • To determine if these risk factors, individually or combined, influence the likelihood of developing aortic stenosis.

Main Methods:

  • Retrospective study comparing 54 patients with isolated aortic stenosis to a control group undergoing angiography for other reasons.
  • Analysis included mathematical model fitting to assess the relationship between risk factors and disease prevalence.
  • Statistical methods were employed to test the effects of diabetes and hypercholesterolemia, both singly and in combination.

Main Results:

  • Both diabetes and hypercholesterolemia were found to be significantly associated with aortic stenosis.
  • The combined effect of diabetes and hypercholesterolemia on the prevalence of aortic stenosis demonstrated a multiplicative interaction.
  • These findings suggest a synergistic role for these metabolic conditions in the development of aortic stenosis.

Conclusions:

  • Diabetes and hypercholesterolemia are associated with an increased prevalence of calcific aortic stenosis.
  • The multiplicative interaction suggests that managing both conditions may be crucial for preventing or mitigating CAS.
  • Further research in broader, unselected populations is warranted to confirm these associations.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...